MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
28.01
-12.60 (-31.03%)
At close: Jul 15, 2025, 4:00 PM
27.95
-0.06 (-0.21%)
After-hours: Jul 15, 2025, 4:55 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $111.64 million as of July 15, 2025. Its market cap has increased by 218.63% in one year.
Market Cap
111.64M
Enterprise Value
118.62M
1-Year Change
218.63%
Ranking
Category
Stock Price
$28.01
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $111.64M, a decrease of -71.11%. That is a compound annual growth rate of -28.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 161.86M | 486.05% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.48B |
| Johnson & Johnson | 373.88B |
| AbbVie | 328.90B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 265.25B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 228.09B |
| AstraZeneca | 222.35B |